Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksandr Petrov

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Diabetes Care|September 9, 2024
Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Glucose-Lowering Medication Under Conditions of Clinical UncertaintyJames H Flory, Jessica S Ancker, Scott Y H Kim, et al.
Clinical Pharmacology in Drug Development|January 3, 2024
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate BiosimilarityIgor Makarenko, Aleksandr Petrov, Bella Belova, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 25, 2012
Differential effects of oxyntomodulin and GLP-1 on glucose metabolismXiaobing Du, Jennifer R Kosinski, Julie Lao, et al.
Veterinary World|November 7, 2022
Clinical and diagnostic characteristics of the development of hepatocardial syndrome in black and white cows in the early lactation periodYury Vatnikov, Andrey Rudenko, Larisa Gnezdilova, et al.
Assay and Drug Development Technologies|May 13, 2008
An automated electrophysiology serum shift assay for K(V) channelsKevin S Ratliff, Aleksandr Petrov, George J Eiermann, et al.
Clinical Pharmacology in Drug Development|December 20, 2024
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune ThrombocytopeniaAleksandr Petrov, Igor Makarenko, Bella Belova, et al.
Bioorganic & Medicinal Chemistry|October 8, 2013
A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activityElisabetta Bianchi, Paul E Carrington, Paolo Ingallinella, et al.
Diabetes|April 20, 2018
GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced HypoglycemiaNina Xiaoyan Li, Stacey Brown, Tim Kowalski, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 7, 2018
Quantifying ceramide kinetics in vivo using stable isotope tracers and LC-MS/MSYing Chen, Olga Berejnaia, Jinqi Liu, et al.
Structure (London, England : 1993)|November 20, 2024
Structural basis of signaling complex inhibition by IL-6 domain-swapped dimersAnna Yudenko, Sergey Bukhdruker, Pavel Shishkin, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Diabetes Care|September 9, 2024
Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Glucose-Lowering Medication Under Conditions of Clinical UncertaintyJames H Flory, Jessica S Ancker, Scott Y H Kim, et al.
Clinical Pharmacology in Drug Development|January 3, 2024
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate BiosimilarityIgor Makarenko, Aleksandr Petrov, Bella Belova, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 25, 2012
Differential effects of oxyntomodulin and GLP-1 on glucose metabolismXiaobing Du, Jennifer R Kosinski, Julie Lao, et al.
Veterinary World|November 7, 2022
Clinical and diagnostic characteristics of the development of hepatocardial syndrome in black and white cows in the early lactation periodYury Vatnikov, Andrey Rudenko, Larisa Gnezdilova, et al.
Assay and Drug Development Technologies|May 13, 2008
An automated electrophysiology serum shift assay for K(V) channelsKevin S Ratliff, Aleksandr Petrov, George J Eiermann, et al.
Clinical Pharmacology in Drug Development|December 20, 2024
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune ThrombocytopeniaAleksandr Petrov, Igor Makarenko, Bella Belova, et al.
Bioorganic & Medicinal Chemistry|October 8, 2013
A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activityElisabetta Bianchi, Paul E Carrington, Paolo Ingallinella, et al.
Diabetes|April 20, 2018
GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced HypoglycemiaNina Xiaoyan Li, Stacey Brown, Tim Kowalski, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 7, 2018
Quantifying ceramide kinetics in vivo using stable isotope tracers and LC-MS/MSYing Chen, Olga Berejnaia, Jinqi Liu, et al.
Structure (London, England : 1993)|November 20, 2024
Structural basis of signaling complex inhibition by IL-6 domain-swapped dimersAnna Yudenko, Sergey Bukhdruker, Pavel Shishkin, et al.
Pageof 4